{"symbol":"JNJ","fiscalQuarter":"Q3-2018","reportDate":"2018-10-16","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2018","postBrief":{"headline":"Johnson & Johnson Misses on EPS \u2014 Stock Down N/A","keyNumbers":[{"metric":"EPS","actual":"$2.05","expected":"N/A","surprise":"-0.52%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing challenges in certain product lines.","They emphasized a focus on innovation and cost management.","The company remains committed to long-term growth despite current pressures."],"summary":"Overall, management expressed a cautious outlook while reaffirming their commitment to strategic initiatives. They acknowledged some headwinds but remain focused on future opportunities."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"This earnings report indicates that Johnson & Johnson faced some challenges this quarter, particularly reflected in their EPS results. The lack of guidance may leave investors uncertain about the company's short-term outlook. The stock reaction is not available, but the management's cautious tone suggests they are navigating a complex market environment.","metaDescription":"Johnson & Johnson (JNJ) Q3 2018 earnings: EPS missed. Stock reaction not available. Full breakdown."}}